Patrick Duxbury > Gowling WLG > London, England > Lawyer Profile

Patrick Duxbury and Robert Breedon lead the practice at Gowling WLG, which is noted for its ‘deep experience‘ in licensing matters and pharmaceutical manufacturing issues. The team regularly assists large pharmaceutical companies such as BioNTech and AstraZeneca, and is known for representing care home and senior facility operators and funders. With his academic background in microbiology and genetics, Duxbury handles an array of transactional issues, including commercialisation deals and collaborations, while Breedon advises both public and private sector clients in the healthcare space on outsourcing contracts and commercial projects.

Recommended for its ‘great commercial acumen’, the Gowling WLG IP practice, which is headed by Kate Swaine, has key strengths that include tech patent litigation, SEP/FRAND litigation and work in the life sciences field, to name a few. Alexandra Brodie is noted for her expertise in the technology sector, leading significant cases in the SEP/FRAND sphere, while Paul Inman has considerable experience in pharma patent infringement and revocation actions. Further strengthening the practice is Patrick Duxbury, who is well-versed in handling transactional matters, and Huw Evans, who routinely handles life sciences and technology related matters. Luke Kempton is particularly active in the biotech and pharma sectors, and Jamie Rowlands routinely represents a multitude of clients in global patent disputes, being especially active in the telecoms space. Matt Hervey and Nick Cunningham are also recommended. Jonathan Ball departed to Norton Rose Fulbright in June 2022.